These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7117899)

  • 21. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.
    Lamp KC; Freeman CD; Klutman NE; Lacy MK
    Clin Pharmacokinet; 1999 May; 36(5):353-73. PubMed ID: 10384859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of atrial natriuretic factor in sodium and water retention in patients with schistosomal hepatic fibrosis.
    Habib YA; Kira LH; el-Sherbini HA; Asser LA; el-Shamy EA; Hatem YA
    J Trop Med Hyg; 1991 Aug; 94(4):272-6. PubMed ID: 1831860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metronidazole metabolism following oral benzoylmetronidazole suspension in children with giardiasis.
    Homeida MA; Daneshmend TK; Ali HM; Kaye CM
    J Antimicrob Chemother; 1986 Aug; 18(2):213-9. PubMed ID: 3759732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Renal lesions in hepatosplenic schistosomiasis].
    Andrade ZA; de Queiroz AC
    Rev Inst Med Trop Sao Paulo; 1968; 10(1):36-40. PubMed ID: 5683035
    [No Abstract]   [Full Text] [Related]  

  • 25. Disposition and metabolism of metronidazole in patients with liver failure.
    Farrell G; Baird-Lambert J; Cvejic M; Buchanan N
    Hepatology; 1984; 4(4):722-6. PubMed ID: 6745863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyanotic syndrome of portal hypertension in hepatosplenic schistosomiasis and portal cirrhosis. Report of four cases.
    MARCHAND EJ; DE JESUS M; BIASCOECHEA ZA
    Am J Cardiol; 1962 Oct; 10():496-506. PubMed ID: 13932816
    [No Abstract]   [Full Text] [Related]  

  • 27. [Functional and immunologic evaluation of prothrombin in the hepatosplenic form of schistosomiasis and hepatic cirrhosis].
    Manoukian N; Borges DR
    Rev Paul Med; 1983; 101(5):182-5. PubMed ID: 6672979
    [No Abstract]   [Full Text] [Related]  

  • 28. Liver collagen synthesis in schistosomiasis mansoni.
    Dunn MA; Kamel R; Kamel IA; Biempica L; Kholy AE; Hait PK; Rojkind M; Warren KS; Mahmoud AA
    Gastroenterology; 1979 May; 76(5 Pt 1):978-82. PubMed ID: 437424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bile composition in bilharzial hepatic fibrosis.
    el Masri SH; Lewin MR; Gumaa K
    Br J Surg; 1977 Jul; 64(7):487-9. PubMed ID: 922308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyroid function and chronic hepatosplenic schistosomiasis: peripheral conversion of thyroxine to 3,5,3'-triiodothyronine and pituitary-thyroid relationship.
    Medeiros-Neto GA; de Kallas WG; Cavaliere H; Knobel M; Mattar E
    J Clin Endocrinol Metab; 1982 Sep; 55(3):403-7. PubMed ID: 6808003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatosplenic schistosomiasis: comparison of sonographic findings in Brazilian and Sudanese patients--correlation of sonographic findings with clinical symptoms.
    Richter J; Zwingenberger K; Ali QM; Lima Wde M; Dacal AR; de Siqueira GV; Doehring-Schwerdtfeger E; Feldmeier H
    Radiology; 1992 Sep; 184(3):711-6. PubMed ID: 1509054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metronidazole pharmacokinetics in patients with hepatic encephalopathy.
    Loft S; Sonne J; Døssing M; Andreasen PB
    Scand J Gastroenterol; 1987 Jan; 22(1):117-23. PubMed ID: 3563404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of chemical constituents of thoracic duct lymph in schistosomal hepatic fibrosis.
    Sadek AM; Guirgis FK; Ayad W; El-Sawy M; Ismal A; Abdel-Hay MM
    Ann Trop Med Parasitol; 1978 Apr; 72(2):139-43. PubMed ID: 666385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of effect of cimetidine on the pharmacokinetics and metabolism of a single oral dose of metronidazole.
    Loft S; Døssing M; Sonne J; Dalhof K; Bjerrum K; Poulsen HE
    Eur J Clin Pharmacol; 1988; 35(1):65-8. PubMed ID: 3220096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compensated and decompensated ammonia tolerance in hepatosplenic schistosomiasis mansoni.
    Warren KS; Rebouças G
    Am J Trop Med Hyg; 1966 Jan; 15(1):32-6. PubMed ID: 5901628
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics of metronidazole as determined by bioassay.
    Ralph ED; Clarke JT; Libke RD; Luthy RP; Kirby WM
    Antimicrob Agents Chemother; 1974 Dec; 6(6):691-6. PubMed ID: 4451343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metronidazole kinetics in dialysis patients.
    Kreeft JH; Ogilvie RI; Dufresne LR
    Surgery; 1983 Jan; 93(1 Pt 2):149-53. PubMed ID: 6849199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The penetration of metronidazole into synovial fluid.
    Sattar MA; Sankey MG; Cawley MI; Kaye CM; Holt JE
    Postgrad Med J; 1982 Jan; 58(675):20-4. PubMed ID: 7088754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum beta-2-microglobulin in intestinal and hepatosplenic bilharziasis.
    Nasser HE; Amer MS; Taha MA; Shawkat A; Abo-Elmaged L; El Missiry AG; Khalil I; Schoukry NA; Abdel Mohsen A; Soliman H
    J Egypt Soc Parasitol; 1983 Dec; 13(2):423-7. PubMed ID: 6363570
    [No Abstract]   [Full Text] [Related]  

  • 40. Disposition and removal of metronidazole in patients undergoing haemodialysis.
    Somogyi A; Kong C; Sabto J; Gurr FW; Spicer WJ; McLean AJ
    Eur J Clin Pharmacol; 1983; 25(5):683-7. PubMed ID: 6662167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.